Ligandrol LGD-4033 - 100 Tablets

In stock

Lab tested · Feb 2022
£49.95

Ligandrol (LGD-4033) as 100 tablets, each containing 10mg. LGD-4033 is a non-steroidal selective androgen receptor modulator discovered by Ligand Pharmaceuticals and later developed by Viking Therapeutics under the code VK5211. It is supplied here as a reference material for laboratory research.

Supplied for Research Purposes Only This information and product is provided for research purposes only. We do not provide any advice on the usage of these products. These products are for sale to persons aged 18 and over only. Customers should check the legality of this product in their own country prior to purchase.

Certificate of analysis

Independently tested by MZ Biolabs

All lab reports
View full certificate from 20 February 2022 (PDF, opens in a new tab)

Latest result

Most recent test
  • 99.69% Purity
  • 9.97 mg Calculated amount 99.69% purity of 10 mg
Sample tested
Not stated
Analysis date
20 February 2022
Laboratory
MZ Biolabs
Lab lot
2022-02-18
Identity
Molecular weight confirmed
Method
Mass Spectrometry & UV

Testing history

  1. 20 February 2022 Purity 99.69% PDF
  2. 21 May 2021 Purity 99.97% PDF

LGD-4033 (Ligandrol), the SARM from Ligand Pharmaceuticals

Background

The LGD prefix and the name Ligandrol both point to Ligand Pharmaceuticals, the Californian company whose chemists discovered the compound. It is a non-steroidal molecule that binds the androgen receptor with high affinity. Chemically it is unrelated to the arylpropionamide SARMs such as ostarine and andarine. Ligand later licensed it to Viking Therapeutics, which renamed it VK5211 and ran early clinical trials, including one in people recovering from hip fracture. It remains an investigational compound and has not been licensed as a medicine.

What researchers have looked at

Preclinical work followed the usual pattern for this class. Castrated male rats were used to compare the response of muscle with that of the prostate, and ovariectomised female rats were used to study bone. A second body of literature is analytical. Because SARMs are on the World Anti-Doping Agency prohibited list, several laboratories have published methods for identifying LGD-4033 and its metabolites, and reference material is needed to develop and validate such methods.

This product

A Dynamic Performance pouch of 100 tablets, with 10mg of Ligandrol LGD-4033 in each tablet. Keep the pouch closed and store it in a cool, dry place away from light. The tablets are supplied as a reference material for laboratory use and are not a medicine or a food supplement.

Synonyms

  • LGD4033
  • VK5211

Products are supplied for research purposes only and are for sale to persons aged 18 and over.